NCT05324696

Brief Summary

Otitis media with effusion (OME) is a common finding affecting children and the main cause of acquired hearing loss in the pediatric age. OBJECTIVES The purpose of the clinical study is to determine whether self-inflation using a new device:

  • It is an effective non-invasive treatment during the watchful waiting period, with the ability to improve hearing loss and prevent surgical treatment;
  • Maintains long-term hearing improvement;

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2020

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

April 6, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 12, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 3, 2023

Completed
Last Updated

August 24, 2022

Status Verified

April 1, 2022

Enrollment Period

2.1 years

First QC Date

April 6, 2022

Last Update Submit

August 22, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Otitis media with effusion resolution proven with normalization of results in the audiological study (tympanogram and audiogram)

    Outcomes assessed by sustained improvement in the audiological study carried out with the following complementary diagnostic tests: audiogram and tympanogram

    3 years

Study Arms (3)

Treatment with placebo device

PLACEBO COMPARATOR

Device similar to the one developed, but which does not generate pressure

Device: autoinflation device

Treatment with a working device

EXPERIMENTAL

Treatment with a functioning device, which generates the necessary pressure to open the Eustachian tube

Device: autoinflation device

Surgical treatment

ACTIVE COMPARATOR

Surgical treatment (myringotomy with placement of ventilation tubes) which is the treatment currently applied in children with otitis media with effusion that do not resolve with medical treatment and/or autoinflation

Device: autoinflation device

Interventions

The authors developed a new standardized, inexpensive and simple device, based on Moniri. The Device is formed by a T tube with a unidirectional valve. A mask with the capacity of covering the child's mouth and nose, providing hermetic seal, and a balloon are connected to 2 ends of the T tube. Blowing the balloon trough the mask, with different types of maneuvers, will force the opening of the Eustachian tube and subsequent reabsorption of the middle ear effusion.

Surgical treatmentTreatment with a working deviceTreatment with placebo device

Eligibility Criteria

Age3 Years - 8 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro Hospitalar Univrsitário do Porto

Porto, 4099-001, Portugal

RECRUITING

MeSH Terms

Conditions

Otitis Media with EffusionHearing Loss

Condition Hierarchy (Ancestors)

Otitis MediaOtitisEar DiseasesOtorhinolaryngologic DiseasesHearing DisordersSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • João Lino, MD

    Instituto de Ciências Biomédicas Abel Salazar

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 6, 2022

First Posted

April 12, 2022

Study Start

November 1, 2020

Primary Completion

December 1, 2022

Study Completion

December 3, 2023

Last Updated

August 24, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations